Enhancer-deleted retroviral vectors restore high levels of superoxide generation in a mouse model of CGD
✍ Scribed by Oliver Schwickerath; Gaby Brouns; Adrian Thrasher; Christine Kinnon; Jürgen Roes; Colin Casimir
- Book ID
- 102337555
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 418 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1099-498X
- DOI
- 10.1002/jgm.557
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background
Retroviral vectors possess many advantages for use in gene therapy protocols, especially within the haematopoietic system. A number of attendant problems, however, still limit their safety in clinical application. The effects of the enhancer present in the retroviral long terminal repeat (LTR) are a major concern for the clinical usage of such vectors, as they can exert a powerful regulatory influence on the genes that surround them.
Methods
To improve the safety and widen the applicability of retroviral vectors for use in gene therapy we have developed an enhancer‐deleted (Δ‐LTR) retroviral vector that retained high titre and demonstrated transcriptional activity in myeloid cells.
Results
When used to correct a mouse model of autosomal recessive chronic granulomatous disease, the Δ‐LTR vectors gave acceptable levels of gene transfer to mouse bone marrow cells. Evidence for a slight preferential expression in myeloid cells was obtained with all the vectors studied. Nitroblue tetrazolium assay of superoxide generation in mouse bone marrow derived haematopoietic colonies revealed that transduction with Δ‐LTR vectors could restore functional NADPH oxidase to cells from these animals. Superoxide assay of peripheral blood confirmed that, although relatively low numbers of cells were transduced, the Δ‐LTR vector was capable of reconstituting very high levels of oxidase activity, comparable to that obtained from normal cells.
Conclusions
The Δ‐LTR vector described here could provide the basis for a new generation of retroviral vectors with improved safety. Copyright © 2004 John Wiley & Sons, Ltd.